ONC
Price
$406.96
Change
+$19.71 (+5.09%)
Updated
Nov 6 closing price
Capitalization
46.04B
145 days until earnings call
Intraday BUY SELL Signals
VRTX
Price
$547.09
Change
+$4.59 (+0.85%)
Updated
Nov 6 closing price
Capitalization
138.67B
95 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ONC vs VRTX

ONC vs VRTX Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
ONC vs. VRTX commentary
Nov 07, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ONC is a Buy and VRTX is a Buy.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for ONC with price predictions
Nov 05, 2026

ONC in -4.14% downward trend, sliding for three consecutive days on November 03, 2026

Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where ONC declined for three days, in 239 of 320 cases, the price declined further within the following month. The odds of a continued downward trend are 75%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day RSI Indicator for ONC moved out of overbought territory on October 22, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 38 similar instances where the indicator moved out of overbought territory. In 26 of the 38 cases, the stock moved lower in the following days. This puts the odds of a move lower at 68%.

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 50 of 64 cases where ONC's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 78%.

The Momentum Indicator moved above the 0 level on November 05, 2026. You may want to consider a long position or call options on ONC as a result. In 60 of 76 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 79%.

The Moving Average Convergence Divergence (MACD) for ONC just turned positive on November 05, 2026. Looking at past instances where ONC's MACD turned positive, the stock continued to rise in 36 of 49 cases over the following month. The odds of a continued upward trend are 73%.

ONC moved above its 50-day moving average on November 04, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for ONC crossed bullishly above the 50-day moving average on October 20, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 14 of 21 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 67%.

Following a +9.09% 3-day Advance, the price is estimated to grow further. Considering data from situations where ONC advanced for three days, in 224 of 302 cases, the price rose further within the following month. The odds of a continued upward trend are 74%.

ONC may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In 192 of 260 cases where ONC Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 74%.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is 42 (best 1 - 100 worst), indicating steady price growth. ONC’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 58 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 92 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ONC’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock better than average.

The Tickeron Valuation Rating of 94 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (8.898) is normal, around the industry mean (2.788). P/E Ratio (69.566) is within average values for comparable stocks, (-0.376). Projected Growth (PEG Ratio) (0.776) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (133.911) among similar stocks. P/S Ratio (6.553) is also within normal values, averaging (440.869).

The Tickeron PE Growth Rating for this company is 97 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

A.I.Advisor
a Summary for VRTX with price predictions
Nov 05, 2026

Momentum Indicator for VRTX turns positive, indicating new upward trend

VRTX saw its Momentum Indicator move above the 0 level on October 20, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 86 similar instances where the indicator turned positive. In 61 of the 86 cases, the stock moved higher in the following days. The odds of a move higher are at 71%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for VRTX just turned positive on October 20, 2026. Looking at past instances where VRTX's MACD turned positive, the stock continued to rise in 41 of 59 cases over the following month. The odds of a continued upward trend are 69%.

VRTX moved above its 50-day moving average on October 28, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for VRTX crossed bullishly above the 50-day moving average on October 30, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 12 of 19 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 63%.

Following a +5.51% 3-day Advance, the price is estimated to grow further. Considering data from situations where VRTX advanced for three days, in 236 of 369 cases, the price rose further within the following month. The odds of a continued upward trend are 64%.

Bearish Trend Analysis

The 10-day RSI Indicator for VRTX moved out of overbought territory on November 02, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 43 similar instances where the indicator moved out of overbought territory. In 25 of the 43 cases, the stock moved lower in the following days. This puts the odds of a move lower at 58%.

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 35 of 63 cases where VRTX's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 56%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where VRTX declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 44%.

VRTX broke above its upper Bollinger Band on October 30, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for VRTX entered a downward trend on October 13, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is 12 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock better than average.

The Tickeron Price Growth Rating for this company is 18 (best 1 - 100 worst), indicating outstanding price growth. VRTX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is 37 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is 41 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of 91 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (6.848) is normal, around the industry mean (2.788). P/E Ratio (31.605) is within average values for comparable stocks, (-0.376). Projected Growth (PEG Ratio) (1.939) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (133.911) among similar stocks. P/S Ratio (10.449) is also within normal values, averaging (440.869).

FUNDAMENTALS RATINGS
ONC vs VRTX: Fundamental Ratings
ONC
VRTX
OUTLOOK RATING
1..100
8232
VALUATION
overvalued / fair valued / undervalued
1..100
94
Overvalued
91
Overvalued
PROFIT vs RISK RATING
1..100
9212
SMR RATING
1..100
5841
PRICE GROWTH RATING
1..100
4218
P/E GROWTH RATING
1..100
9737
SEASONALITY SCORE
1..100
4950

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

VRTX's Valuation (91) in the Biotechnology industry is in the same range as ONC (94). This means that VRTX’s stock grew similarly to ONC’s over the last 12 months.

VRTX's Profit vs Risk Rating (12) in the Biotechnology industry is significantly better than the same rating for ONC (92). This means that VRTX’s stock grew significantly faster than ONC’s over the last 12 months.

VRTX's SMR Rating (41) in the Biotechnology industry is in the same range as ONC (58). This means that VRTX’s stock grew similarly to ONC’s over the last 12 months.

VRTX's Price Growth Rating (18) in the Biotechnology industry is in the same range as ONC (42). This means that VRTX’s stock grew similarly to ONC’s over the last 12 months.

VRTX's P/E Growth Rating (37) in the Biotechnology industry is somewhat better than the same rating for ONC (97). This means that VRTX’s stock grew somewhat faster than ONC’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ONCVRTX
RSI
ODDS (%)
Bearish Trend 2 days ago
68%
Bearish Trend 2 days ago
58%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
78%
Bearish Trend 2 days ago
56%
Momentum
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
71%
MACD
ODDS (%)
Bullish Trend 2 days ago
73%
Bullish Trend 2 days ago
69%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
65%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
71%
Bullish Trend 2 days ago
68%
Advances
ODDS (%)
Bullish Trend 2 days ago
74%
Bullish Trend 8 days ago
64%
Declines
ODDS (%)
Bearish Trend 4 days ago
75%
Bearish Trend 4 days ago
44%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
76%
Bearish Trend 2 days ago
57%
Aroon
ODDS (%)
Bullish Trend 2 days ago
74%
Bearish Trend 2 days ago
44%
COMPARISON
Comparison
Nov 07, 2026
Stock price -- (ONC: $387.25 vs. VRTX: $542.50)
Brand notoriety: ONC and VRTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ONC: 266% vs. VRTX: 180%
Market capitalization -- ONC: $46.04B vs. VRTX: $137.5B
ONC [@Biotechnology] is valued at $46.04B. VRTX’s [@Biotechnology] market capitalization is $137.5B. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $138.67B. The average market capitalization across the [@Biotechnology] industry is $2.16B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ONC’s FA Score shows that 0 FA rating(s) are green while VRTX’s FA Score has 2 green FA rating(s).

  • ONC’s FA Score: 0 green, 5 red.
  • VRTX’s FA Score: 2 green, 3 red.
According to our system of comparison, VRTX is a better buy in the long-term than ONC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ONC’s TA Score shows that 8 TA indicator(s) are bullish while VRTX’s TA Score has 5 bullish TA indicator(s).

  • ONC’s TA Score: 8 bullish, 2 bearish.
  • VRTX’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, ONC is a better buy in the short-term than VRTX.

Price Growth

ONC (@Biotechnology) experienced а +4.22% price change this week, while VRTX (@Biotechnology) price change was +0.46% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.94%. For the same industry, the average monthly price growth was -3.91%, and the average quarterly price growth was -15.16%.

Reported Earning Dates

ONC is expected to report earnings on Mar 31, 2027.

VRTX is expected to report earnings on Feb 09, 2027.

Industries' Descriptions

@Biotechnology (+7.94% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
Interact to see
Advertisement

ONC and

Correlation & Price change

A.I.dvisor indicates that over the last year, ONC has been loosely correlated with VRTX. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if ONC jumps, then VRTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ONC
1D Price
Change %
ONC100%
+2.51%
VRTX - ONC
39%
Loosely correlated
-1.19%
HALO - ONC
38%
Loosely correlated
-5.66%
AXON - ONC
37%
Loosely correlated
-9.81%
GOSS - ONC
35%
Loosely correlated
-5.33%
ARGX - ONC
35%
Loosely correlated
-3.93%
More

VRTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, VRTX has been loosely correlated with INCY. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if VRTX jumps, then INCY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VRTX
1D Price
Change %
VRTX100%
+0.85%
INCY - VRTX
47%
Loosely correlated
+1.39%
RPRX - VRTX
46%
Loosely correlated
-0.40%
BMRN - VRTX
45%
Loosely correlated
-0.16%
EDIT - VRTX
44%
Loosely correlated
+0.78%
REGN - VRTX
43%
Loosely correlated
+0.16%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HDL10.650.16
+1.53%
Super Hi International Holding Ltd ADR
BSM14.35-0.16
-1.10%
Black Stone Minerals LP
SWK115.27-3.06
-2.59%
Stanley Black & Decker
HUMA0.40-0.06
-12.11%
Humacyte
CHSN2.35-1.01
-30.06%
Chanson International Holding